Real-world data: most stop semaglutide or tirzepatide within a year
Tirzepatide · News
Compound hub
A dual GIP and GLP-1 receptor agonist studied in metabolic research. (Demo description.)
Tirzepatide · News
Tirzepatide · News
Personal experiences, moderated before publishing. Not verified and not medical advice.
Share your storyOctober 20, 2026